The news came July 21 during the insurer’s second-quarter earnings call.
Anthem joins UnitedHealth in waiting to cover the drug since its FDA approval, while a handful of Blue Cross Blue Shield affiliates have declined to cover it.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
